289 related articles for article (PubMed ID: 32228425)
1. Current Understanding and Unknown Aspects of the Treatment of Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Opportunities for Future Studies.
Alesaeidi S; Darvishi M; Dabiri S; GhasemiAdl M; Jafarieh A; Tavakolpour S
Curr Rheumatol Rev; 2020; 16(4):257-266. PubMed ID: 32228425
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
[TBL] [Abstract][Full Text] [Related]
4. Granulomatosis with polyangiitis (Wegener's).
Puéchal X
Joint Bone Spine; 2020 Dec; 87(6):572-578. PubMed ID: 32562697
[TBL] [Abstract][Full Text] [Related]
5. Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies.
Granel J; Korkmaz B; Nouar D; Weiss SAI; Jenne DE; Lemoine R; Hoarau C
Front Immunol; 2021; 12():571933. PubMed ID: 33679731
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
7. [Granulomatosis with polyangiitis (Wegener's granulomatosis)].
Karras A; Guiard E; Lévi C; Thervet E
Presse Med; 2012 Oct; 41(10):1014-23. PubMed ID: 22902722
[TBL] [Abstract][Full Text] [Related]
8. Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients.
Thai LH; Charles P; Resche-Rigon M; Desseaux K; Guillevin L
Autoimmun Rev; 2014 Mar; 13(3):313-8. PubMed ID: 24225075
[TBL] [Abstract][Full Text] [Related]
9. Limited granulomatosis with polyangiitis presenting as an isolated lung lesion.
Begum S; Srinivasan S; Kathirvelu S; Vaithy A
Indian J Pathol Microbiol; 2020; 63(4):611-614. PubMed ID: 33154316
[TBL] [Abstract][Full Text] [Related]
10. Targeted immunotherapy strategies in ANCA-associated vasculitis.
Puéchal X
Joint Bone Spine; 2019 May; 86(3):321-326. PubMed ID: 30201478
[TBL] [Abstract][Full Text] [Related]
11. Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized Disease.
Joshi L; Tanna A; McAdoo SP; Medjeral-Thomas N; Taylor SR; Sandhu G; Tarzi RM; Pusey CD; Lightman S
Ophthalmology; 2015 Jun; 122(6):1262-8. PubMed ID: 25745876
[TBL] [Abstract][Full Text] [Related]
12. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
13. Granulomatosis with polyangiitis and facial palsy: Literature review and insight in the autoimmune pathogenesis.
Iannella G; Greco A; Granata G; Manno A; Pasquariello B; Angeletti D; Didona D; Magliulo G
Autoimmun Rev; 2016 Jul; 15(7):621-31. PubMed ID: 26851550
[TBL] [Abstract][Full Text] [Related]
14. [Wegener's granulomatosis].
Pagnoux C; Teixeira L
Presse Med; 2007 May; 36(5 Pt 2):860-74. PubMed ID: 17363211
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
[TBL] [Abstract][Full Text] [Related]
16. Intracranial granuloma in a patient with granulomatosis with polyangiitis under rituximab maintenance: A case report.
Ince B; Eroğlu E; Barburoğlu M; Yalçinkaya Y; Artim-Esen B; Gül A; Inanç M
Int J Rheum Dis; 2024 Jan; 27(1):e14887. PubMed ID: 37610040
[TBL] [Abstract][Full Text] [Related]
17. 4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis.
Granel J; Lemoine R; Morello E; Gallais Y; Mariot J; Drapeau M; Musnier A; Poupon A; Pugnière M; Seren S; Nouar D; Gouilleux-Gruart V; Watier H; Korkmaz B; Hoarau C
Front Immunol; 2020; 11():573040. PubMed ID: 33101296
[TBL] [Abstract][Full Text] [Related]
18. Clinical profile and management of granulomatosis with polyangiitis-associated scleritis from a tertiary care hospital in South India.
Mohanan-Earatt A; Biswas J
Indian J Ophthalmol; 2023 Jan; 71(1):146-152. PubMed ID: 36588225
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
20. Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.
Lynch JP; Derhovanessian A; Tazelaar H; Belperio JA
Semin Respir Crit Care Med; 2018 Aug; 39(4):434-458. PubMed ID: 30404111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
